Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 10 mg | $44 | In Stock | |
| 25 mg | $61 | In Stock | |
| 50 mg | $89 | In Stock | |
| 100 mg | $123 | In Stock | |
| 500 mg | $297 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | In Stock | 
| Description | Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis. | 
| Targets&IC50 |  Immunosuppressive:100 μM | 
| In vitro | Mizoribine selectively inhibits guanine ribonucleotide synthesis in purified T-cells, while the mechanism of 6-thioguanine (6MP) appears to rely more on the depletion of adenine ribonucleotides. In a dose-dependent manner, Mizoribine at 1-50 mg/mL suppresses T-cell proliferation induced by all tested stimuli by 10-100%. This suppression is reversible with the addition of guanosine to replenish the guanine nucleotide pool when 50 mM is incorporated. Furthermore, Mizoribine impedes HCV RNA replication with an IC50 of 100 μM and causes a reduction in intracellular GTP levels, with GTP supplementation reversing its antiproliferative effect. | 
| In vivo | Administration of 5 or 10 mg/kg Mizoribine resulted in increased expression of MCP-1, OPN, and TGF-β1 mRNA in untreated OLETF rats. Simultaneously, this dose of Mizoribine inhibited urinary albumin excretion and attenuated the progression of glomerulosclerosis, renal interstitial fibrosis, and macrophage infiltration in the rat kidneys. | 
| Synonyms | NSC 289637, HE 69, Bredinin | 
| Molecular Weight | 259.22 | 
| Formula | C9H13N3O6 | 
| Cas No. | 50924-49-7 | 
| Smiles | O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(O)=C(C(N)=O)N=C2 | 
| Relative Density. | 1.4155 g/cm3 (Estimated) | 
| Color | White | 
| Appearance | Solid | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (231.46 mM), Sonication is recommended.   Ethanol: < 1 mg/mL (insoluble or slightly soluble)  H2O: 47 mg/mL (181.31 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
| Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
| H2O/DMSO 
 | ||||||||||||||||||||||||||||||||||||
 For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .  A total of 10 animals were administered, and the formula you used is 5%
 A total of 10 animals were administered, and the formula you used is 5%  DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first. main solution, add 300 μLPEG300
 main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O
 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
 mix well and clarify
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.